Business ❯ Pharmaceutical Industry ❯ Drug Manufacturers

Pricing Strategies

Market Competition Market Access Market Impact Market Regulations Market Agreements Consumer Discounts Negotiations with Government Market Dynamics Negotiation Tactics Market Compliance Rebates Market Reactions Investment Commitments Rebate Systems International Agreements Counter Offers Market Regulation Market Power Government Regulations Pfizer and Bristol-Myers Squibb

Trump Adds Nine Pharma Giants to Drug Pricing Deals, Reaching 14 Signatories as TrumpRx Nears Launch

The voluntary MFN agreements promise lower Medicaid prices with cash-purchase discounts via TrumpRx.gov starting in January.

Medicare’s First Negotiated Drug Prices Take Effect Jan. 1, Cutting 2026 Costs

White House Finalizes GLP-1 Price Deal With Lilly and Novo, Setting $50 Medicare Copays

RFK Jr. To Announce New HHS Plan To Cut U.S. Drug Prices Today

Trump Gives Pharma CEOs 60 Days to Adopt Most-Favored-Nation Drug Pricing

Bristol Myers Squibb and Pfizer to Offer Eliquis at 40% Cash-Price Discount